Study of safety and efficacy of DKY709 alone or in combination with PDR001 in patients with advanced solid tumors.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-513281-19-00

Acronym

CDKY709A12101C

Enrollment

Registered

2024-08-08

Start date

2024-11-25

Completion date

Unknown

Last updated

2025-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cutaneous Melanoma, Microsatellite Stable Colorectal Cancer, Nasopharyngeal Carcinoma, Non-Small Cell Lung Cancer, Triple Negative Breast Cancer

None listed

Sex/Gender

All

Age

18 Years to No maximum

Germany, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026